Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1973 Sep;8(3):341–348. doi: 10.1128/iai.8.3.341-348.1973

Association of Group B Coxsackieviruses with Cases of Pericarditis, Myocarditis, or Pleurodynia by Demonstration of Immunoglobulin M Antibody

Nathalie J Schmidt 1, Robert L Magoffin 1, Edwin H Lennette 1
PMCID: PMC422854  PMID: 4199715

Abstract

Tests for immunoglobulin M (IgM) antibody to group B coxsackieviruses were performed on sera from 259 patients with a clinical diagnosis of pericarditis, myocarditis, or pleurodynia on whom there were no definitive serological or virus isolation findings to establish a viral etiology, and on 259 “control” patients with clinical diagnoses of viral or mycoplasmal pneumonia or pneumonitis. IgM antibodies to coxsackievirus types B1, B3, B4, B5, and B6 were detected by a micro-immunodiffusion technique, and antibodies to virus type B2 were detected by reduction of neutralizing antibodies with ethanethiol. Of the patients with pericarditis, myocarditis, or pleurodynia, 27% (70) had IgM antibody to group B coxsackieviruses, as compared with 8% in the control group. On retrospective review of the clinical diagnosis, some of the patients in the control group with IgM antibody were found to have had additional clinical findings which could be attributed to a coxsackievirus infection. Coxsackievirus IgM antibody was demonstrable in 30% of 113 patients in the study group for whom virus isolation had been attempted with negative results. The presence of coxsackievirus IgM is discussed in relation to the time of serum collection, age of the patients, and month of onset of illness.

Full text

PDF
341

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Artenstein M. S., Cadigan F. C., Jr, Buescher E. L. Clinical and epidemiological features of Coxsackie group B virus infections. Ann Intern Med. 1965 Oct;63(4):597–603. doi: 10.7326/0003-4819-63-4-597. [DOI] [PubMed] [Google Scholar]
  2. BUSSELL R. H., KARZON D. T., BARRON A. L., HALL F. T. Hemagglutination-inhibiting, complement-fixing and neutralizing antibody responses in ECHO 6 infection, including studies on heterotypic responses. J Immunol. 1962 Jan;88:47–54. [PubMed] [Google Scholar]
  3. Bell E. J., Grist N. R. Further studies of enterovirus infections in cardiac disease and pleurodynia. Scand J Infect Dis. 1970;2(1):1–6. doi: 10.3109/inf.1970.2.issue-1.01. [DOI] [PubMed] [Google Scholar]
  4. Berkovich S., Rodriguez-Torres R., Lin J. S. Virologic studies in children with acute myocarditis. Am J Dis Child. 1968 Feb;115(2):207–212. doi: 10.1001/archpedi.1968.02100010209009. [DOI] [PubMed] [Google Scholar]
  5. Connolly J. H., Haire M., Hadden D. S. Measles immunoglobulins in subacute sclerosing panencephalitis. Br Med J. 1971 Jan 2;1(5739):23–25. doi: 10.1136/bmj.1.5739.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Eckert H. L., Portnoy B., Salvatore M. A., Ressler R. Group B, Coxsackie virus infection in infants with acute lower respiratory disease. Pediatrics. 1967 Apr;39(4):526–531. [PubMed] [Google Scholar]
  7. Haire M., Hadden D. S. Immunoglobulin responses in rubella and its complications. Br Med J. 1970 Jul 18;3(5715):130–132. doi: 10.1136/bmj.3.5715.130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Helin M., Savola J., Lapinleimu K. Cardiac manifestations during a Coxsackie B5 epidemic. Br Med J. 1968 Jul 13;3(5610):97–99. doi: 10.1136/bmj.3.5610.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. JAVETT S. N., HEYMANN S., MUNDEL B., PEPLER W. J., LURIE H. I., GEAR J., MEASROCH V., KIRSCH Z. Myocarditis in the new newborn infant; a study of an outbreak associated with Coxsackie group B virus infection in a maternity home in Johannesburg. J Pediatr. 1956 Jan;48(1):1–22. doi: 10.1016/s0022-3476(56)80111-x. [DOI] [PubMed] [Google Scholar]
  10. JOHNSON R. T., PORTNOY B., ROGERS N. G., BUESCHER E. L. Acute benign pericarditis. Virologic study of 34 patients. Arch Intern Med. 1961 Dec;108:823–832. doi: 10.1001/archinte.1961.03620120007002. [DOI] [PubMed] [Google Scholar]
  11. Koontz C. H., Ray C. G. The role of Coxsackie group B virus infections in sporadic myopericarditis. Am Heart J. 1971 Dec;82(6):750–758. doi: 10.1016/0002-8703(71)90195-5. [DOI] [PubMed] [Google Scholar]
  12. LENNETTE E. H., SCHMIDT N. J. Studies on the development and persistence of complement-fixing and neutralizing antibodies in human poliomyelitis. Am J Hyg. 1957 Mar;65(2):210–238. doi: 10.1093/oxfordjournals.aje.a119866. [DOI] [PubMed] [Google Scholar]
  13. LENNETTE E. H., SHINOMOTO T. T., SCHMIDT N. J., MAGOFFIN R. L. Observations on the neutralizing antibody response to group B Coxsackie viruses in patients with central nervous system disease. J Immunol. 1961 Mar;86:257–266. [PubMed] [Google Scholar]
  14. MURRAY E. S., O'CONNOR J. M., GAON J. A. DIFFERENTIATION OF 19S AND 7S COMPLEMENT FIXING ANTIBODIES IN PRIMARY VERSUS RECRUDESCENT TYPHUS BY EITHER ETHANETHIOL OR HEAT. Proc Soc Exp Biol Med. 1965 May;119:291–297. doi: 10.3181/00379727-119-30161. [DOI] [PubMed] [Google Scholar]
  15. Millar J. H., Fraser K. B., Haire M., Connolly J. H., Shirodaria P. V., Hadden D. S. Immunoglobulin M specific for measles and mumps in multiple sclerosis. Br Med J. 1971 May 15;2(5758):378–380. doi: 10.1136/bmj.2.5758.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. NIITU Y. COXSACKIE B1 VIRUS ASSOCIATED WITH ATYPICAL PNEUMONIA FOUND IN A MASS CHEST X-RAY SURVEY AMONG SCHOOL CHILDREN IN SENDAI IN 1960. Sci Rep Res Inst Tohoku Univ Med. 1965 Mar;12:75–85. [PubMed] [Google Scholar]
  17. NULL F. C., Jr, CASTLE C. H. Adultpericarditis and myocarditis due to Coxsackie virus group B, type 5. N Engl J Med. 1959 Nov 5;261:937–942. doi: 10.1056/NEJM195911052611903. [DOI] [PubMed] [Google Scholar]
  18. PLAGER H., BEEBE R., MILLER J. K. Coxsackie B-5 pericarditis in pregnancy. Arch Intern Med. 1962 Nov;110:735–738. doi: 10.1001/archinte.1962.03620230181024. [DOI] [PubMed] [Google Scholar]
  19. Ray C. G., Sciple G. W., Holden P., Chin T. D. Acute, febrile CNS illnesses in an endemic area of Texas. Public Health Rep. 1967 Sep;82(9):785–793. [PMC free article] [PubMed] [Google Scholar]
  20. SCHMIDT N. J., DENNIS J., FROMMHAGEN L. H., LENNETTE E. H. SEROLOGIC REACTIVITY OF CERTAIN ANTIGENS OBTAINED BY FRACTIONATION OF COXSACKIE VIRUSES IN CESIUM CHLORIDE DENSITY GRADIENTS. J Immunol. 1963 Apr;90:654–662. [PubMed] [Google Scholar]
  21. SCHMIDT N. J., DENNIS J., LENNETTE E. H., HO H. H., SHINOMOTO T. T. ANTIBODY RESPONSES OF RHESUS (MACACA MULATTA) MONKEYS EXPERIMENTALLY INFECTED WITH COXSACKIEVIRUSES OF GROUP B AND GROUP A, TYPE 9. I. ANTIBODY RESPONSES WITH THE COXSACKIEVIRUS GROUP. J Immunol. 1965 Jul;95:54–69. [PubMed] [Google Scholar]
  22. SCHMIDT N. J., LENNETTE E. H. Gel double diffusion studies with group B and group A, type 9 Coxsackie viruses. I. The technique and reactions obtained with hyperimmune animal sera and human sera. J Immunol. 1962 Jul;89:85–95. [PubMed] [Google Scholar]
  23. Sainani G. S., Krompotic E., Slodki S. J. Adult heart disease due to the Coxsackie virus B infection. Medicine (Baltimore) 1968 Mar;47(2):133–147. doi: 10.1097/00005792-196803000-00003. [DOI] [PubMed] [Google Scholar]
  24. Schmidt N. J., Lennette E. H., Dennis J. Characterization of antibodies produced in natural and experimental coxsackievirus infections. J Immunol. 1968 Jan;100(1):99–106. [PubMed] [Google Scholar]
  25. Smith W. G. Coxsackie B myopericarditis in adults. Am Heart J. 1970 Jul;80(1):34–46. doi: 10.1016/0002-8703(70)90035-9. [DOI] [PubMed] [Google Scholar]
  26. WALKER S. J., McNAUGHTON G. A., McLEAN D. M. Coxsackie B5 virus infections in children: Toronto, 1958. Can J Public Health. 1959 Nov;50:461–467. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES